Follow-The-Filings

Security

Moderna Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

14 owners 2 new 1 exit max 0.3% (Two Sigma Investments, LP)

owners 14
max % 0.3%
tracked value $1.7B
qoq N 2 A 6 R 3 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Two Sigma Investments, LP 2025 Q4 stale 0.3% Exit -0.31 pp 7,342,096 $217M hist
Renaissance Technologies LLC 2026 Q1 0.1% Add +0.04 pp 881,200 $45M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 41,584,782 $1.2B hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add +0.02 pp 1,019,208 $52M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce -0.06 pp 666,532 $34M hist
Ray Dalio - Bridgewater Associates, LP 2026 Q1 0.0% Add +0.02 pp 74,822 $4M hist
Norges Bank 2025 Q4 stale 0.0% Exit -0.01 pp 2,702,832 $80M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% New 0.0% 197,844 $10M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 133,815 $7M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 489,770 $25M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Add 0.00 pp 38,315 $2M hist
Natixis Advisors, LLC 2026 Q1 0.0% New 0.0% 13,490 $685 hist
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% Reduce 0.00 pp 5,191 $264 hist
Ancora Advisors LLC 2026 Q1 0.0% 497 $25 hist
Philippe Laffont - Coatue Management LLC exited 2026 Q1 last 2025 Q4 0.0% Exit -0.01 pp 200,000 $6M hist

SEC filings

Recent issuer filings from EDGAR · 25 shown

Filed Form Detail Links
10-Q 10-Q
8-K 2.02,9.01
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
8-K 5.02,7.01,9.01
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 4
4 PRIMARY DOCUMENT
8-K 5.03,5.07,9.01
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT
4 PRIMARY DOCUMENT

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6.85B $3.24B $1.94B
Gross profit * $2.16B $1.77B $1.08B
Gross margin * 31.5% 54.8% 55.3%
Net income -$4.71B -$3.56B -$2.82B
Net margin * -68.8% -110.0% -145.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $10.32B $8.1B $6.54B
Total non-current assets * $8.1B $6.04B $5.79B
Total assets $18.43B $14.14B $12.34B
Total current liabilities $3.02B $2.21B $1.99B
Total non-current liabilities * $1.56B $1.04B $1.7B
Total equity $13.85B $10.9B $8.65B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$3.12B -$3B -$1.87B
Cash from investing $4.21B $1.95B $1.95B
Cash from financing -$1.38B $56M $593M
Net change in cash -$289M -$999M $668M

ownership over time

filing count by report period · click a bar for that quarter’s holders